Clinical trials recruiting for Gastroesophageal Junction Adenocarcinoma
11
Recruiting trials
46
US states with sites
21
Countries
9%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Bevacizumab | 2 |
| Carboplatin | 2 |
| Docetaxel | 2 |
| Nivolumab | 2 |
| Oxaliplatin | 2 |
| Pembrolizumab | 2 |
| 5-Fluorouracil | 1 |
| 5-Fluorouracil (5-FU) | 1 |
| APL-101 Oral Capsules | 1 |
| Capecitabine | 1 |
| Cisplatin | 1 |
| FOLFIRI Protocol | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 9 |
| Florida | 8 |
| Texas | 7 |
| Massachusetts | 6 |
| Tennessee | 6 |
| Washington | 5 |
| Illinois | 4 |
| Arizona | 3 |
| Connecticut | 3 |
| Indiana | 3 |
| Michigan | 3 |
| Minnesota | 3 |
Top cities
Boston, Massachusetts 5Houston, Texas 5Los Angeles, California 5Nashville, Tennessee 5San Antonio, Texas 4Seattle, Washington 4Chicago, Illinois 3Duarte, California 3New York, New York 3Sioux Falls, South Dakota 3
Self-screener
Recruiting trials
- A Multicenter Cancer Biospecimen Collection Study
- A Study of KK2269 in Adult Participants With Solid Tumors
- A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
Related conditions
Trials recruiting for Gastroesophageal Junction Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Pancreatic cancer 870Colorectal cancer 1359Urothelial Carcinoma 29Esophageal Squamous Cell Carcinoma 14Esophageal Adenocarcinoma 15Breast cancer 2239Renal cell carcinoma 28Melanoma 487Non-small cell lung cancer 507
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Gastroesophageal Junction Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.